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Non-sorbitol-fermenting (NSF) Escherichia coli O157:H7 is the primary Shiga toxin-producing E. coli (STEC)
serotype associated with human infection. Since 1988, sorbitol-fermenting (SF) STEC O157:NM strains have
emerged and have been associated with a higher incidence of progression to hemolytic-uremic syndrome (HUS)
than NSF STEC O157:H7. This study investigated bacterial factors that may account for the increased pathogenic
potential of SF STEC O157:NM. While no evidence of toxin or toxin expression differences between the two O157
groups was found, the SF STECO157:NM strains adhered at significantly higher levels to a human colonic cell line.
Under the conditions tested, curli were shown to be the main factor responsible for the increased adherence to
Caco-2 cells. Notably, 52 of 66 (79%) European SF STEC O157:NM strains tested bound Congo red at 37C and
this correlated with curli expression. In a subset of strains, curli expression was due to increased expression from
the csgBAC promoter that was not always a consequence of increased csgD expression. The capacity of SF STEC
O157:NM strains to express curli at 37C may have relevance to the epidemiology of human infections as curliated
strains could promote higher levels of colonization and inflammation in the human intestine. In turn, this could lead
to increased toxin exposure and an increased likelihood of progression to HUS.
Shiga toxin-producing Escherichia coli (STEC) strains of se-
rogroup O157 are associated with human disease, including
diarrhea, hemorrhagic colitis (HC), and hemolytic-uremic syn-
drome (HUS). While non-sorbitol-fermenting (NSF) STEC
O157:H7 strains are important human pathogens worldwide
(37), sorbitol-fermenting (SF) STEC O157:NM strains have
emerged as important pathogens in continental Europe (28).
SF STEC O157:NM strains were first recognized causing HUS
in children in Bavaria, Germany, in 1988 (28), and since then,
these strains have been isolated from patients throughout Ger-
many (20, 29), including a further outbreak in Bavaria that
resulted in 28 cases of HUS and three fatalities (2). The first
isolation of SF STEC O157:NM strains outside Germany oc-
curred in the Czech Republic in 1995 (7). There have since
been reports of this pathogen causing diarrhea or HUS in
Hungary (28), Finland (30), another region of the Czech Re-
public (8), Austria (41), and Sweden (S. Lo¨fdahl, personal
communication). Infection with SF STEC O157:NM was not
reported outside continental Europe until 2002, when it was
isolated in Australia (4) and Scotland (1). It was subsequently
isolated from patients in England (24) and Ireland (18). Be-
tween April and May 2006, 18 cases of SF STEC O157:NM
infection were identified in Scotland, 13 of which were associ-
ated with a nursery (13). A further two cases of SF STEC
O157:NM infection were identified in August 2006.
There is some evidence to suggest that SF STEC O157:NM
strains are more frequently associated with HUS than NSF
STEC O157:H7 strains. For example, in Germany the proba-
bility of development of HUS after infection with SF STEC
O157:NM is 1:2, whereas after infection with NSF STEC
O157:H7, this ratio is 1:6 (M. Bielaszewska and H. Karch,
personal communication). A similar situation appears to be the
case in Scotland, where 10 out of 20 cases of SF STEC
O157:NM infection identified between April and August 2006
progressed to HUS. While host susceptibility between out-
breaks may account for such differences, it is also possible that
SF STEC O157:NM strains are more virulent than NSF STEC
O157:H7 strains. Shiga toxins are responsible for the serious
consequences of STEC O157 infection, including HC and
HUS. Increased toxicity could be accounted for by (i) a more
potent toxin variant, (ii) increased toxin expression, or (iii)
colonization of the human intestine at higher levels leading to
a greater exposure to toxin. Recently published work has in-
dicated that there are no significant differences in the Stx2
proteins encoded by SF STEC O157:NM and NSF STEC
O157:H7 strains (6), and a report indicates that the toxicity
levels may be similar (20).
In terms of intestinal colonization, there are multiple factors
that may contribute to STEC O157 adherence. Both SF and
NSF STEC O157 strains possess a type III secretion system
that is responsible for intimate attachment and attaching and
effacing lesion formation. In contrast to NSF STEC O157:H7,
SF STEC O157:NM strains contain a complete efa1 gene (26),
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which encodes the enterohemorrhagic E. coli factor for adher-
ence (Efa1) (39). Attachment may also be mediated by sur-
face-expressed appendages such as fimbriae. SF STEC
O157:NM uniquely possess the sfp gene cluster which encodes
novel Sfp fimbriae (SF enterohemorrhagic E. coli O157 fim-
briae, plasmid encoded) (9). At least 16 putative fimbrial oper-
ons have been identified in NSF STEC O157:H7 (22, 36, 44),
including the well-characterized adhesins type 1 fimbriae and
curli. While the function (25) or capacity to express many of
these fimbrial adhesins appears to have been lost by NSF
STEC O157:H7 strains (36), SF STEC O157:NM strains may
be different.
The objective of this study was to compare both phenotypic
and genotypic characteristics of SF STEC O157:NM and NSF
STEC O157:H7 strains isolated from cases of infection in Scot-
land. In particular, the research addressed whether SF STEC
O157:NM strains could be considered more virulent as a result
of increased toxin expression or enhanced colonization poten-
tial.
MATERIALS AND METHODS
Bacterial strains. The STEC O157 strains used in this study are detailed in
Table 1. Wild-type SF STEC O157:NM strains H8824, H8432, H8489, H8757,
and H8478 were isolated during the 2006 Scottish outbreak cluster and shared an
indistinguishable pulsed-field gel electrophoresis profile. A single SF STEC
O157:NM isolate (H2687) was obtained from an isolated case in Scotland (35)
and was associated with bloody diarrhea. Four NSF STEC O157:H7 strains were
included for comparison. Three strains (H77, H511, and 1477/AI) were isolated
from separate Scottish outbreaks (11, 42, 47), and the remaining NSF STEC
O157:H7 isolate was the sequenced strain EDL933 (44). Two representative SF
STEC O157:NM strains (H2687 and H8824) and two NSF STEC O157:H7
strains (EDL933 and 1477/AI) were analyzed in the phenotypic assays. A further
66 SF STEC O157:NM strains, isolated in Europe, were also analyzed for their
potential to express curli.
Characterization PCRs. Multiplex PCR for the detection of genes encoding
Shiga toxin 1 (stx1), Shiga toxin 2 (stx2), intimin (eae), and enterohemolysin
(hlyA) was performed as described previously (43). The gene encoding the
flagellin subunit (fliC) was detected and characterized using the fliC restriction
fragment length polymorphism method (16). PCR to detect the presence of the
16-bp deletion in the fim switch that controls type 1 fimbriae expression was
performed as previously described (34).
Nucleotide sequencing. Nucleotide sequencing was performed using an ABI
Prism BigDye terminator cycle sequencing kit, version 3.1 (Applied Biosystems),
and reactions were analyzed on an ABI 3730 DNA sequencer. The nucleotide
sequences of stx2 from the six Scottish SF STEC O157:NM strains were deter-
mined following PCR amplification of stxA2 and stxB2 using a Taq PCR core kit
(Qiagen) and primer pairs stx2Aseq_F1 and stx2Aseq_R2 and stx2Bseq_F and
stx2Bseq_R, respectively. (Table 2 details the primer sequences and cycling
conditions for the PCRs.) The amplicons were purified and sequenced directly
with the PCR primers and internal stxA2 primers stx2Aseq_F2 and stx2Aseq_R1
(Table 2). For sequence analysis of the region required for curli formation
(csgBAC and csgDEFG operons and the csgB-to-csgD intergenic region), the
entire region was amplified with five separate PCRs using iProof high-fidelity
DNA polymerase (Bio-Rad) and primer pairs curli1F and curli1R, curli2F and
curli2R, curli3F and curli3R, curli4F and curli4R, and curli5F and curli5R (Table
2). PCR products were purified and ligated into the StrataClone PCR cloning
vector, pSC-B, with a StrataClone blunt PCR cloning kit (Stratagene); trans-
formed following the manufacturer’s instructions; and sequenced with primers
T3 and T7.
Vero cell cytotoxicity assay. Bacterial strains were cultured in minimal essen-
tial medium-HEPES, supplemented with glucose (final concentration of 0.2%)
and 0.25 M Fe(NO3)3, at 37°C at 200 rpm for 24 h. Mitomycin C (0.5 g/ml)
was added when required to cultures at an optical density at 600 nm (OD600) of
0.3. Bacterial cultures were centrifuged (4,000  g for 20 min), and supernatants
were filter sterilized through low-protein-binding 0.22-m filters. Culture fil-
trates were added to Vero cells (seeded in 96-well plates), and the cytotoxicity
assay was performed at 37°C in 5% CO2 for 72 h. Following the 72-h incubation,
Vero cells were washed with phosphate-buffered saline (PBS) and fixed with 2%
formalin in PBS. Quantification of viable Vero cells was determined by staining
with crystal violet solution (0.13% crystal violet, 0.065% phenol, 5% ethanol, 2%
formaldehyde in PBS) for 1 h. Plates were rinsed with distilled water and dried.
Crystal violet was released from the cells with 10% acetic acid. Absorbance
measurements were taken at 590 nm.
Adherence assays to Caco-2 cells. Caco-2 cells were seeded into eight-chamber
microscope slides at a density of 1  105 cells/well and incubated at 37°C in 5%
CO2 for 48 h prior to adherence assays. Bacteria were cultured for 24 h at 37°C
on CFA agar plates (1% Casamino Acids, 0.15% yeast extract, 0.005% MgSO4,
0.0005% MnCl2, 1.5% agar) and in CDMT broth [13 mM K2HPO4, 6 mM
KH2PO4, 8 mM (NH4)2SO4, 2 mM sodium citrate, 0.4 mM MgSO4, 0.2%
Casamino Acids, 0.2% glucose, 5 M CaCl2, 0.01% tryptone], which have both
been used previously to promote fimbrial expression (9, 15). Bacteria were
harvested from CFA plates in PBS. Bacterial cultures were diluted to an OD600
of 0.5, and 300 l was added to the Caco-2 cells. Adherence assays were per-
formed at 37°C in 5% CO2 for 2 h. This time point was chosen because we
wanted to study initial attachment and avoid the complication of adherence due
to induction of type III secretion. The bacterial suspension was removed, and the
cells were washed with PBS three times prior to fixation with 4% paraformal-
dehyde. Bacteria attached to cells were labeled by indirect immunofluorescence
using rabbit anti-O157 antisera (1:100 [Mast Assure]) and Alexa Fluor 568
secondary antibody (1:1,000 [Molecular Probes]). Slides were examined by flu-
orescence microscopy, and the number of bacteria per field was counted for
randomly selected fields in each well for at least 20 fields. Images were captured
with Leica software.
TABLE 1. STEC O157 strains used in this study
Serotype Strain(s) Country oforigin Source or reference
NSF STEC O157:H7 EDL933 United States 44
H77, H511, 1477/AI Scotland 11, 42, 47
SF STEC O157:NM H2687 Scotland 35
H8824, H8432, H8489, H8757, H8478 Scotland 2006 Scottish outbreak cluster
493/89, 2260/96, 3072/96, 340/97, 1527/97, 3873/98, 4368/98,
0355/99, 2696/99, DN940/00, 2518/00, 3317/00, 080/01,
164/01, 689/01, E02/16, E02/115, E02/129, E02/149, E02/
172, E02/207, E02/456, E02/679, E02/774, E02/793, E02/
809, E02/813, E02/817, E02/819, E02/829, E02/848, E02/
852, E02/870, E02/878, E02/879, E03/1, E03/23, E03/49,
E03/53, E03/55, E03/71, E03/86, E03/88, E03/100, E03/
104, E03/106, E03/108, E03/198, E03/200, E04/1278,
E05/15, E05/18, E05/22, E05/114, E06/443, E06/449,
E06/481, E06/484, E06/486, E06/494, E06/537, E07/50,
E07/59, E07/64, E07/65, E07/67
Germany H. Karch, Muenster University,
Germany
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Biofilm assays. Bacteria were cultured statically overnight at 28°C in LB, CFA,
and CDMT broths. Cultures were diluted 1:100 in fresh medium, and 200 l/well
was added to 96-well polystyrene plates. Plates were incubated at 28°C for 24 h
and 48 h. Bacterial adherence to microtiter well surfaces was determined by
crystal violet staining, as described earlier, except that washes were done with
PBS. Sterile medium was included as a control, and the A590 was subtracted from
the other values.
Yeast cell agglutination. A single colony of the strain to be tested was inocu-
lated into 5 ml LB broth and incubated statically at 37°C for 24 h. The culture was
subcultured into a further 5 ml LB broth and incubated statically for another
24 h. Subculturing was repeated once more. Yeast cell agglutination was carried
out by mixing 15 l bacterial culture with an equal volume of baker’s yeast
suspension (10 mg/ml) on glass slides, and the degree of clumping was assessed.
Mannose inhibition of agglutination was confirmed using 3% -D-mannose in the
yeast suspension.
fim switch orientation assay. Orientation of the fim switch was carried out as
described previously (23, 33, 45). Briefly, PCR was used to amplify a 603-bp
region that incorporates the invertible fimA promoter element. Template DNA
for the PCR was prepared by adding 50 l of bacterial culture (following 3 days
of consecutive subculture in LB broth) or a colony from cultures grown on CFA
agar to 50 l MilliQ H2O and boiling at 100°C for 15 min. The PCR-amplified
product was digested asymmetrically with HinfI, and the fragments were sepa-
rated on a 4% polyacrylamide Tris-borate-EDTA gel. Fragments were visualized
after staining with ethidium bromide.
Immunostaining of surface curli. Bacteria were cultured on CFA agar and in
CFA and CDMT broths. Bacterial cultures were fixed in 4% paraformaldehyde.
Curli fimbriae were labeled using mouse anti-SEF17 monoclonal antibody (1:
100) and fluorescein isothiocyanate-conjugated anti-mouse immunoglobulin sec-
ondary antibody (1:500 [Sigma-Aldrich]). Slides were examined by fluorescence
microscopy, and the images were captured with Leica software.
Construction and measurement of plasmid-based promoter-GFP fusions. The
promoter for csgBAC (curli main subunit) was amplified by PCR from strain
H8824 using primer pair csgBACprom_F and csgBACprom_R (Table 2). The
promoter was cloned in frame to gfp in pAJR70 (46), creating translational
fusions. The promoter for csgD (positive transcriptional regulator of the csgBAC
operon) cloned into pAJR70 was constructed previously (36). The fusions were
transformed into the appropriate STEC O157 background, and single transfor-
mants were cultured on CFA agar and in CDMT broth (both containing 25 l
ml1 chloramphenicol [CAM]). Bacteria were harvested from CFA-CAM agar
plates in CFA-CAM broth. Total green fluorescent protein (GFP) produced by
the population was determined by analyzing 100-l aliquots of culture (OD600 of
0.5) in a FLUOstar Optima fluorimeter. Promoterless plasmid pAJR70 in each
strain background acted as a control for background fluorescence and was sub-
tracted from the other values.
Inhibition adherence assays. Bacteria were cultured on CFA agar as described
previously and prior to adding bacteria to Caco-2 cells, aliquots of bacterial
cultures were incubated in the presence or absence of anticurli monoclonal
antibody (1:100). Adherence to Caco-2 cells and subsequent staining, visualiza-
tion, and enumeration of results were carried out as described previously.
Detection of curli expression. To screen for surface curli expression bacteria
were cultured on CFA-Congo red (CR) indicator plates (0.01% CR) for 24 h at
37°C. Curliated bacteria are able to bind CR dye and stain red. The ability of
selected strains to bind CR was also assessed quantitatively as described previ-
ously (17). Briefly, bacteria harvested from CFA agar plates were incubated in
the presence of 100 M CR at 37°C in an orbital shaker for 30 min. Bacterial
suspensions were centrifuged (10,000  g for 10 min) and the absorbance of free
CR in the supernatant was measured at 490 nm.
Construction of a csgBA deletion and complementation. The csgA and csgB
genes were deleted from SF O157:NM strain H8824 by allelic exchange (45, 46).
Briefly, regions flanking csgBA were amplified using primer pairs F1upCsgBA/
F1downCsgBA and F2upCsgBA/F2downCsgBA (Table 2) and cloned into
pIB307 (45, 46) to produce pTD06. A sacB kan cassette was then cloned between
the two flanking regions to create pTD08. This was then used to replace csgBA
following electrotransformation of H8824. The clean deletion was then produced
by exchanging in the region from pTD06 into this intermediate strain to create
ZAP1125. The csgBA deletion was verified by its resistance profile and PCR
screening. To complement the deletion, the csgBAC genes were amplified from
H8824 using primer pair CsgBAC1/CsgBAC2 (Table 2) and this fragment was
cloned into pWSK29 (54) to make pTD10. csgBAC can be induced from the lac
promoter of this plasmid using 1 mM IPTG (isopropyl--D-thiogalactopyrano-
side). Following induction, pTD10 complemented the csgBA deletion strain for
CR binding and curli expression (data not shown).
Statistical analysis. For the initial Caco-2 adherence assays and curli inhibi-
tion assays, bacteria per field counts were log10 transformed and analyzed with
mixed models using the REML (restricted maximum likelihood) directive, drop-
ping nonsignificant terms for fixed effects. A difference between predicted means
was considered significant if it was greater than twice the standard error of
difference. For graphical representation, predicted means and confidence inter-
vals were back-transformed. These statistical calculations were performed in
Genstat, 10th ed. The Vero cell cytotoxicity and biofilm assay data were analyzed
TABLE 2. Primers and PCR conditions used in this study
Primer Nucleotide sequence (533)a
PCR conditions (30 cycles) Amplicon
size (bp)Denaturing Annealing Extension
stx2Aseq_F1 TACCAGGCTCGCTTTTGCGG 94°C, 30 s 60°C, 45 s 72°C, 80 s 1,110
stx2Aseq_R2 CGCCATTGCATTAACAGAAGC
stx2Aseq_F2 CCATGACAACGGACAGCAG
stx2Aseq_R1 CTGTATCTGCCTGAAGCGTAAGGC
stx2Bseq_F CCAGAATGTCAGATAACTGGC 94°C, 30 s 58°C, 45 s 72°C, 30 s 476
stx2Bseq_R GGCAACTGTCAACTGACTG
curli1F CGCTTAAACAGTAAATGCCG 98°C, 10 s 60°C, 30 s 72°C, 35 s 1,046
curli1R CCGCATGGTGACCAACGA
curli2F TTCCTTATGAAGCTGGGGC 98°C, 10 s 60°C, 30 s 72°C, 35 s 1,054
curli2R CGGAATCAGCCCTCCTTAC
curli3F CGCTGATGAACAACGAACG 98°C, 10 s 60°C, 30 s 72°C, 35 s 1,028
curli3R CCCGTCGCTGATTGCTGC
curli4F CTCCACACCACCGTGGAC 98°C, 10 s 60°C, 30 s 72°C, 35 s 1,047
curli4R GCTTGCAGAGCAAGTGCAG
curli5F GGCAGGTGTTGTTCCTCAG 98°C, 10 s 60°C, 30 s 72°C, 35 s 886
curli5R CCTTGAGGGTTGTGTTATCC
csgBACprom_F cgcggatccGTTGTACATTTGGTTTTTATTGCAC 94°C, 15 s 60°C, 30 s 72°C, 60 s 524
csgBACprom_R cggggtaccCAATTTGTTTTTCATGTTGTCACC
F1upCsgBA aagagctcGCACACCTGACAGCTGCC 94°C, 30 s 60°C, 30 s 72°C, 60 s 739
F1downCsgBA aaggatccTCACCCTGGACCTGGTCG
F2upCsgBA aaggatccCGCGACCGCTCATCAGTAC 94°C, 30 s 60°C, 30 s 72°C, 60 s 960
F2downCsgBA aactgcagTTCATAACGCCTCCTTACACC
CsgBAC1 aaggatccGTTGCGTTAACAACCAAGTTG 94°C, 30 s 60°C, 30 s 72°C, 90 s 1,016
CsgBAC2 aaggtaccGCTGATTCGCAGCAGACCA
a The lowercase portions of some sequences are nonmatching, and the underlined bases show the incorporation of restriction sites.
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by analysis of variance in Genstat, 10th ed. Caco-2 adherence assays with the
curli deletion mutant and the European SF STEC O157:NM strains and the
promoter expression data were analyzed using the Student’s t test in Excel.
Nucleotide sequence accession numbers. Nucleotide sequences from this study
have been deposited in the GenBank database under the accession numbers
listed in Table 3.
RESULTS
Characterization of STEC O157 isolates. The six SF STEC
O157:NM strains isolated from infections in Scotland (Mate-
rials and Methods) were found to possess an H7 fliC restriction
fragment length polymorphism pattern. Multiplex PCR for the
detection of genes encoding Shiga toxins 1 and 2, intimin, and
enterohemolysin demonstrated that the SF STEC O157:NM
isolates were positive for stx2, eae, and hlyA and negative for
stx1. The three NSF STEC O157:H7 isolates from Scottish
outbreaks were also positive for stx2, eae, and hlyA and negative
for stx1. STEC O157:H7 EDL933 was confirmed to be positive
for stx1, stx2, eae, and hlyA.
Sequencing of stx2. The nucleotide sequences of stx2 were
determined for the six Scottish SF STEC O157:NM isolates.
The sequences from the five isolates obtained from the 2006
Scottish cluster (with GenBank accession numbers detailed in
Table 3) were identical and the same as those published for
three previously characterized SF STEC O157:NM strains (6).
Their A and B subunit genes differed from the published E.
coli EDL933 sequence by seven nucleotides and one nucleo-
tide, respectively, and encode a Stx2 protein which differed
from Stx2 from EDL933 by a single amino acid residue in each
of the subunits. The stx2 sequence from SF STEC O157:NM
isolate H2687 (GenBank accession no. EU526759) differed
from EDL933 by a single nucleotide in the A subunit, and the
B subunits were identical. This SF STEC O157:NM isolate had
a predicted protein sequence for Stx2 identical to that of
EDL933.
Vero cell cytotoxicity assays. To determine if Stx2 expression
levels could vary between the two STEC O157 groups, stan-
dard Vero cell cytotoxicity assays were carried out with culture
filtrates of strains without and after induction with mitomycin
C. A single SF STEC O157:NM isolate from the 2006 Scottish
outbreak cluster (H8824) was analyzed along with SF STEC
O157:NM strain H2687 isolated from a single case in 2003 and
compared with NSF STEC O157:H7 strains EDL933 and
1477/AI (Fig. 1). One-way analysis of variance analysis of Vero
cell survival following exposure to basal levels of toxin in cul-
tures filtrates from the four STEC O157 uninduced cultures
demonstrated significant variation (P  0.001). The source of
this variation is almost entirely due to EDL933, which has a
different Shiga toxin background (Stx1 and Stx2) from the
other three STEC O157 isolates (Stx2 alone). Induction with
mitomycin C reduced Vero cell survival for all toxin-positive
strains tested, but there was no significant difference in Vero
cell survival rates between the four STEC O157 strains exam-
ined following induction (P 	 0.723). E. coli O157:H7
TUV93-0, a toxin-negative derivative of EDL933, was included
as a negative control. Therefore, under the in vitro conditions
tested there was no evidence of increased toxin expression and
activity from the SF STEC O157:NM isolates in comparison
with the NSF STEC O157:H7 isolates.
Adherence assays. To investigate if there are differences in
the capacities of the two O157 groups to adhere to human
intestinal epithelial cells, NSF STEC O157:H7 strains EDL933
and 1477/AI and SF STEC O157:NM isolates H2687 and
H8824, cultured under two different conditions, were tested for
their capacity to bind to Caco-2 cells. Significantly higher levels
of adherence (50-fold) were observed for the SF STEC
O157:NM strains compared with the NSF STEC O157:H7
strains when cultured on CFA agar, whereas little difference
was observed between the two groups when cultured in CDMT
broth (Fig. 2A). Images showing the adherence of STEC O157
strains, cultured on CFA agar, to Caco-2 cells are provided in
Fig. 2B. It was apparent that the SF STEC O157:NM strains,
but not NSF STEC O157:H7 strains, autoaggregated following
CFA culture, and as a result, biofilm formation was also tested.
SF STEC O157:NM isolates demonstrated increased adher-
ence to polystyrene microtiter plates in comparison with the
NSF STEC O157:H7 isolates under the different conditions
tested (Fig. 2C and data not shown). It was evident that cul-
FIG. 1. Vero cell cytotoxicity of culture filtrates from NSF STEC
O157:H7 strains (EDL933 and 1477/AI) and SF STEC O157:NM
strains (H2687 and H8824) with (unshaded bars) and without (shaded
bars) mitomycin C (0.5 g/ml). TUV93-0, a VT-negative derivative of
EDL933, serves as a negative control. Viable Vero cells, following 72 h
of exposure to culture filtrates, were quantified by crystal violet stain-
ing and subsequent absorbance measurement of crystal violet in solu-
tion. Vero cell survival is expressed relative to untreated controls not
exposed to bacterial culture filtrates. Error bars indicate standard
errors of the means.
TABLE 3. Details and accession numbers of nucleotide sequences
determined in this study
Strain Sequence description
Sequence
length
(bp)
Accession
no.
H2687 stx2 1,248 EU526759
H8824 stx2 1,248 EU526760
H8432 stx2 1,248 EU526761
H8489 stx2 1,248 EU526762
H8757 stx2 1,248 EU526763
H8478 stx2 1,248 EU526764
340/97 csgBA and csgDEFG operons and
csgB-to-csgD intergenic region
4,544 EU554557
080/01 csgBA and csgDEFG operons and
csgB-to-csgD intergenic region
4,544 EU554558
E06/486 csgBA and csgDEFG operons and
csgB-to-csgD intergenic region
4,544 EU554559
H8824 csgBA and csgDEFG operons and
csgB-to-csgD intergenic region
4,544 EU554560
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turing the two SF STEC O157:NM strains in CDMT broth
promoted biofilm formation but did not increase adherence to
Caco-2 cells. This indicates that the same combination of fac-
tors is not required for the two different adherence pheno-
types.
Analysis of type 1 fimbria expression by NSF STEC O157:H7
and SF STEC O157:NM. NSF E. coli O157:H7 strains have
been shown to contain a 16-bp deletion in the fim switch that
controls type 1 fimbria expression (34, 45), thus preventing
inversion of the fim switch to the on orientation and the ex-
pression of type 1 fimbriae. A PCR designed to detect the
presence of this deletion was used to analyze the two groups of
STEC O157 strains. The SF STEC O157:NM strains did not
contain the deletion (Fig. 3A, lanes 5 to 10), whereas the
deletion was present in the NSF STEC O157:H7 strains tested
(Fig. 3A, lanes 1 to 4). When the two groups of STEC O157
strains were cultured under conditions optimal for expression
FIG. 2. Adherence of NSF STEC O157:H7 strains (EDL933 and
1477/AI) and SF STEC O157:NM strains (H2687 and H8824) cultured
with different growth media. (A) Adherence to Caco-2 cells after 2 h
of incubation at 37°C. The indicated strains were cultured on CFA agar
(shaded bars) and in CDMT broth (unshaded bars). Microscopy was
used to determine the number of bacteria per field for at least 20 fields.
Data were log10 transformed and analyzed within mixed models using
the REML directive. The graph represents back-transformed pre-
dicted means, and error bars define 95% confidence interval values.
(B) Visualization of adherence to Caco-2 cells by immunofluorescence
microscopy. The indicated strains were cultured on CFA agar at 37°C,
and the micrographs show bacteria (stained red) adherent to Caco-2
cells after 2 h of incubation at 37°C. (C) Adherence to polystyrene
microtiter plates after 24 h and 48 h of incubation at 28°C. Bacterial
adherence was quantified by crystal violet staining of bacteria and
subsequent absorbance measurement (590 nm) of released crystal vi-
olet. Background levels were determined for sterile media and were
subtracted from the other values. Error bars indicate standard errors
of the means.
FIG. 3. Analysis of type 1 fimbria expression by STEC O157
strains. (A) PCR analysis of the fim switch deletion using STEC O157:
H7-specific primers. NSF STEC O157:H7 strains EDL933, H77, H511,
and 1477/AI (lanes 1 to 4, respectively) generate a 943-bp product
indicating the presence of the deletion that is absent in the SF STEC
O157:NM strains H2687, H8824, H8432, H8489, H8757, and H8478
(lanes 5 to 10, respectively). Lane 11 contains a DNA-negative control,
and lane M contains a 100-bp molecular size marker. (B and C) PCR
and restriction digestion of the fim switch from isolates indicating the
expression status within the bacterial population. (B) The isolates were
cultured under conditions optimal for type 1 fimbria expression (3-day
subculture in LB broth, statically at 37°C). The results of the yeast cell
agglutination assay are summarized below the gel image. The fim
switch was detected in both the on and off orientations for the two SF
STEC O157:NM strains examined (H2687 and H8824, lanes 3 and 4,
respectively) but only in the off orientation for the two NSF STEC
O157:H7 strains analyzed (EDL933 and 1477/AI, lanes 1 and 2, re-
spectively). (C) When cultured on CFA agar plates, the fim switch in
the on orientation was only detected in one SF STEC O157:NM strain
(H2687, lane 3) but not H8824 (lane 4) or the two NSF STEC O157:H7
strains (EDL933 and 1477/AI, lanes 1 and 2, respectively). Lane M
contains a 100-bp molecular size marker.
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of type 1 fimbriae (3-day subculture in LB broth, statically at
37°C), only the SF STEC O157:NM strains exhibited mannose-
sensitive agglutination of yeast cells and had the fim switch in
both the off and on orientations (Fig. 3B). In comparison,
when SF STEC O157:NM strains were cultured on CFA agar,
as for the adherence assays, the majority of the bacterial pop-
ulation had the fim switch in the off orientation (Fig. 3C, lanes
3 and 4).
Analysis of curli expression by NSF STEC O157:H7 and SF
STEC O157:NM. CR binding is a well-established method to
demonstrate surface curli expression by enteric bacteria (3, 21,
52). The STEC O157 strains were cultured on CFA-CR indicator
plates at 37°C, and while the NSF STEC O157:H7 strains,
EDL933 and 1477/AI, were negative as expected (10, 52), the SF
STEC O157:NM strains, H2687 and H8824, were positive (data
not shown). Additional evidence for curli expression was provided
by immunostaining with an anticurli monoclonal antibody. When
the bacteria were cultured on CFA agar or in CFA broth, the
majority of aggregated SF STEC O157:NM bacteria exhibited
fluorescent surface staining (Fig. 4A, middle panels), while the
NSF STEC O157:H7 strains were negative (Fig. 4A, top panels).
When the bacteria were cultured in CDMT, there was no surface
staining of either STEC O157 group (data not shown). Further-
more, the SF STEC O157:NM strains demonstrated significantly
higher levels of expression from the csgBAC curli promoter com-
pared with the NSF STEC O157:H7 strains when cultured on
CFA agar (Fig. 4B). Taken together, these data indicate that the
SF STEC O157:NM strains tested express curli at 37°C on CFA
agar.
The contribution of curli to SF STEC O157:NM adherence.
To evaluate the significance of curli in the adherence of SF
STEC O157:NM strains to Caco2 cells, inhibition assays were
carried out in the presence and absence of anticurli monoclo-
nal antibody. The SF STEC O157:NM isolates cultured on
CFA agar demonstrated a significant inhibition of adherence
to Caco-2 cells in the presence of the antibody (Fig. 5A). To
further substantiate the role of curli in the adherence, csgBA
was deleted in SF STEC O157:NM strain H8824 to generate
ZAP1125. This strain could be complemented for CR binding
and curli expression using pTD10 (induced csgBAC [data not
shown]). The csgBA deletion strain did not bind CR and was
negative for curli expression as determined by immunofluores-
cence (Fig. 4A, bottom panel). The adherence of this strain to
Caco-2 cells was significantly reduced (P  0.001) compared to
the parent strain and was equivalent to the non-curli-express-
ing NSF STEC O157:H7 strain EDL933 (Fig. 5B).
Analysis of curli expression by European SF STEC O157:
NM. To determine whether curli expression at 37°C is a com-
mon attribute of SF STEC O157:NM strains, a collection of 66
SF STEC O157 strains collected by Helge Karch’s group
(Muenster, Germany) (9, 26, 28) were analyzed for their po-
tential to bind CR on CFA-CR indicator plates. CR binding
was confirmed for a subset of the strains by a quantitative
method (Materials and Methods). A total of 52/66 (79%) were
assessed as positive for CR binding. To further demonstrate
the association of CR binding with curli expression and Caco-2
cell adherence, two of these CR-positive strains (E02/879 and
E06/486) and two CR-negative strains (340/97 and 080/01)
were analyzed by immunofluorescence using the anticurli
monoclonal antibody and tested in adherence assays. Both
CR-positive strains expressed curli and adhered at significantly
higher levels to the Caco-2 cells compared with the CR-nega-
tive strains that did not express curli (Fig. 6A and B). Curli
expression on CFA at 37°C is therefore a common property of
SF STEC O157:NM strains.
Investigation of differential curli expression in SF STEC
O157:NM strains. To establish if sequence variation in curli
loci could account for the differences in curli expression be-
tween strains, the nucleotide sequences of the relevant regions
(csgBAC and csgDEFG operons and the csgB-to-csgD inter-
FIG. 4. Analysis of curli expression by STEC O157 strains.
(A) Curli detection by immunofluorescence microscopy. Phase-con-
trast and fluorescence micrographs are shown of NSF STEC O157:H7
EDL933 (top panel), SF STEC O157:NM strain H8824 (middle
panel), and SF STEC O157:NM strain H8824
csgBA (bottom panel)
stained for curli using an anticurli monoclonal antibody following
culture on CFA medium at 37°C as described in Materials and Meth-
ods. (B) csgBAC curli promoter activity in STEC O157 strains. Expres-
sion from the csgBAC promoter was determined in the indicated
strains using a promoter-GFP fusion as described in Materials and
Methods. Shaded and unshaded bars represent values obtained fol-
lowing culture of the bacteria on CFA agar and in CDMT broth,
respectively. Background fluorescence levels were determined for the
promoterless plasmid pAJR70 and subtracted. The data are expressed
as relative fluorescence units (RFU). A single asterisk indicates that,
following culture on CFA agar, expression from the csgBAC promoter
for SF STEC O157:NM strain H2687 was significantly higher than that
for NSF STEC O157:H7 strains EDL933 and 1477/AI (P  0.001).
Double asterisks indicate that, following culture on CFA agar, expres-
sion from the csgBAC promoter for SF STEC O157:NM strain H8824
was significantly higher than that for NSF STEC O157:H7 strains
EDL933 and 1477/AI (P  0.001). Error bars indicate standard errors
of the means.
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genic region) were determined for SF STEC O157:NM strains
340/97, 080/01, E06/486, and H8824. (GenBank accession
numbers are detailed in Table 3.) The sequences of the entire
region from strains 080/01, E06/486, and H8824 were identical,
and strain 340/97 only differed from them by a single nucleo-
tide in the csgD gene. The putative CsgG, CsgF, CsgE, CsgD,
CsgB, CsgA, and CsgC proteins encoded by the four SF STEC
O157:NM strains should be identical.
Given that the curli expression differences are not accounted
for by mutations or changes in the curli operons themselves, it is
likely that regulation acting on the csgBAC promoter must differ
between these strains. This could be on the csgBAC promoter via
differences in CsgD activator levels or on the csgBAC promoter
independent of the CsgD level (3, 52). To investigate the expres-
sion of csgBAC and csgD in wild-type SF STEC O157:NM,
promoter-GFP fusion constructs were transformed into different
SF STEC O157:NM backgrounds. Following the culture of
transformed strains on CFA-CAM agar plates, expression of
csgBAC::gfp was found to be higher in strains E02/879, E06/486,
and H8824 than in strains 340/97 and 080/01 (Fig. 6C). These
results correlate with CR binding data and curli expression. In
contrast, while csgD::gfp expression was significantly higher in one
strain (H8824), which could account for the increase in csgBAC
expression and curli production, it was equivalent in the four
other strains tested, two of which express curli on CFA medium
at 37°C (Fig. 6C). This indicates that curli expression in these
strains may be driven by regulators other than CsgD acting di-
rectly on the csgBAC promoter.
DISCUSSION
SF STEC O157:NM strains have emerged as significant hu-
man pathogens in continental Europe, causing diarrheal dis-
ease often resulting in life-threatening HUS. Of particular
concern is that 10 out of 20 Scottish patients infected with SF
STEC O157:NM in 2006 progressed to HUS. This is consistent
with findings in Germany, where humans infected by these
strains are more likely to progress to HUS. This compares to
NSF STEC O157:H7 infections that are typically associated
with HUS at lower frequencies (5 to 10%) (19, 37). As clinical
cases with SF STEC O157:NM are uncommon, host factors in
these cases may be responsible for a bias toward HUS. These
include age, clinical history, or treatment issues such as the
administration of antibiotics and/or antimotility agents. How-
ever, the aim of this research was to investigate the hypothesis
that bacterial factors are the cause of the increased association
of SF STEC O157:NM with HUS.
Basic characterization of the Scottish SF STEC O157:NM
strains showed that they possessed the genes encoding Shiga
toxin 2, intimin, and hemolysin. This is in accord with all
previous studies on SF STEC O157:NM strains (4, 7, 8, 14, 20,
30). It is possible that a higher HUS rate following SF STEC
O157:NM infection compared to NSF STEC O157:H7 infec-
tion could be accounted for by a more active toxin or the
release of more toxin during infection. In the present study, the
predicted protein sequence for Stx2 produced by the SF STEC
O157:NM strains was either identical to or differed by a single
amino acid in the A and B subunits from Stx2 from NSF STEC
O157:H7 EDL933. The levels of toxin released by strains un-
der induced and uninduced in vitro conditions were examined,
and there was no evidence of increased toxin expression from
the SF STEC O157:NM isolates. Thus, toxin sequence varia-
tion and increased toxin release are unlikely to account for any
differences in virulence between SF and NSF STEC O157
strains. However, it is appreciated that in vivo conditions may
result in expression differences not observed in vitro.
Alternatively, SF STEC O157:NM strains may colonize the
human intestine in higher numbers, resulting in increased ex-
posure to toxin. To test this, we compared the potential of SF
STEC O157:NM and NSF STEC O157:H7 strains to adhere to
a human colon carcinoma cell line. Culture of the strains on
CFA agar plates at 37°C resulted in up to 50 times more SF
STEC O157:NM bacteria than NSF STEC O157:H7 bacteria
adhering to Caco-2 cells within 2 h. While type III secretion-
based intimate attachment is likely to be important for intes-
tinal colonization (12, 49), type III secretion profiles and levels
were similar for the strains analyzed in this study (data not
FIG. 5. Contribution of curli to Caco-2 cell adherence. (A) Inhibi-
tion of adherence using anticurli antibody. SF STEC O157:NM strains
H2687 and H8824 were cultured on CFA agar and incubated in the
absence (shaded bars) and presence (unshaded) of anticurli monoclo-
nal antibody. Microscopy was used to determine the number of bac-
teria per field for 30 fields. Data were log10 transformed and analyzed
within mixed models using the REML directive. The graph represents
back-transformed predicted means, and error bars define 95% confi-
dence interval values. (B) Comparative binding studies of a curli de-
letion mutant and wild-type strains. Strain SF STEC O157:NM H8824
was deleted for csgBA (Materials and Methods) and was demonstrated
not to bind CR or express curli (Fig. 4A, bottom panel). The adher-
ence of this strain to Caco-2 cells was compared with its parent and
NSF STEC O157:H7 EDL933. Microscopy was used to determine the
number of bacteria per field for 30 fields. Error bars define standard
deviations. The asterisk indicates that the CR-positive SF STEC
O157:NM strain H8824 adhered to Caco-2 cells at significantly higher
levels than the 
csgBA derivative of this strain (P  0.001).
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shown). Consequently, initial adherence is more likely to in-
volve surface-expressed factors such as fimbriae.
An initial observation in this study was that the SF STEC
O157:NM strains tested could bind CR when cultured on CFA
medium at 37°C. This assay is commonly applied at 28°C to detect
expression of thin aggregative fimbriae called curli (3, 52). In the
present study, curli expression by the strains was substantiated by
antibody staining and promoter fusion analysis. Analysis of a
larger collection of SF STEC O157:NM strains (n	 66) (Table 1)
indicated that 79% could bind CR when cultured on CFA me-
dium at 37°C. For the subset tested, this phenotype again corre-
lated with curli expression (Fig. 6). In contrast, the majority of
NSF E. coli O157:H7 strains are considered not to express curli
under in vitro conditions (10, 52), and our data support this. Curli
are an established adhesin, and so their contribution to the in-
creased adherence of SF STEC O157:NM strains compared to
NSF STEC O157:H7 strains was examined by construction of a
curli mutant. The absence of curli expression reduced the binding
capacity of the strain to a level comparable to that of the NSF
STEC O157:H7 strains tested, indicating that, under these con-
ditions, curli expression was the main factor responsible for ad-
herence to cells. It is appreciated that these strains have multiple
surface factors that can contribute to epithelial cell binding, and
these are likely to play an important role in vivo. For example, we
have confirmed in this study that SF STEC O157:NM strains can
express type 1 fimbriae, in contrast to NSF STEC O157:H7 strains
(34, 45), corroborating the recent findings of Shaikh et al. (48). In
addition, SF E. coli O157:NM strains have been shown to possess
a unique fimbrial cluster encoded on their large plasmid,
pSFO157, which mediates the expression of Sfp fimbriae (9).
Recently published work demonstrates that Sfp fimbriae are ex-
pressed by SF STEC O157:NM strains cultured under anaerobic
conditions on solid media simulating the colonic environment and
that the induction of Sfp fimbriae on wild-type SF STEC
O157:NM strains correlated with increased adherence to Caco-2
and HCT-8 cells (38).
FIG. 6. Analysis of curli expression and adherence among selected European SF STEC O157:NM strains. (A) Curli detection by immunoflu-
orescence microscopy. Phase-contrast and fluorescence micrographs are shown for the indicated strains stained for curli using an anticurli
monoclonal antibody following culture on CFA medium at 37°C as described in Materials and Methods. (B) Adherence of selected strains to
Caco-2 cells. The indicated strains were cultured on CFA agar, and their adherence to Caco-2 cells was determined after 2 h of incubation at 37°C.
SF STEC O157:NM strain H8824 was included as a positive control. Microscopy was used to determine the number of bacteria per field for 30
fields. CR binding which correlates with curli expression (CFA, 37°C) is indicated for the strains below the graph. Error bars define standard
deviations. Single asterisks indicate that, following culture on CFA agar, the CR-positive SF STEC O157:NM strain E02/879 adhered to Caco-2
cells at significantly higher levels than the CR-negative SF STEC O157:NM strains 340/97 and 080/01 (P  0.001). Double asterisks indicate that,
following culture on CFA agar, the CR-positive SF STEC O157:NM strain E06/486 adhered to Caco-2 cells at significantly higher levels than the
CR-negative SF STEC O157:NM strains 340/97 and 080/01 (P  0.01). (C) csgBAC and csgD promoter activity in selected strains. The indicated
strains were transformed with plasmid-based promoter-GFP fusion constructs, and expression of csgBAC::gfp (shaded bars) and csgD::gfp
(unshaded bars) was measured following the culture of transformed strains on CFA-CAM agar plates. Background fluorescence levels were
determined for the promoterless plasmid pAJR70 and subtracted. The data are expressed as relative fluorescence units (RFU). Error bars indicate
standard errors of the means. Single asterisks indicate that, following culture on CFA-CAM agar, expression from the csgBAC promoter for
CR-positive SF STEC O157:NM strains E02/879, E06/486, and H8824 was significantly higher than that for CR-negative SF STEC O157:NM strain
340/97 (P  0.02). Expression from the csgBAC promoter for strains E02/879 and H8824 was also significantly higher than that for strain 080/01
(P  0.002). Double asterisks indicate that, following culture on CFA-CAM agar, expression from the csgD promoter for strain H8824 was
significantly higher than that for strains 340/97, 080/01, E02/879, and E06/486 (P  0.001).
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In E. coli, two divergently transcribed operons, csgBAC and
csgDEFG, are required for curli formation (21). The csgBAC
operon encodes CsgA, the main subunit protein, and CsgB, the
nucleator protein (3). CsgC, encoded by the third gene (csgC)
in the csgBAC operon, has no reported role in curli formation
(3). The csgDEFG operon encodes four accessory proteins
required for curli assembly, where CsgD is the positive tran-
scriptional regulator of the csgBAC operon (3). The curli loci
from four SF STEC O157:NM strains—two curli-expressing
strains and two that did not express curli under the conditions
tested—were sequenced, and there were no changes detected
that could account for the differences in curli expression. In
particular, there were no sequence differences in the csgB-to-
csgD intergenic region. This is significant as nucleotide changes
in the csgD promoter region have been associated with varia-
tion in curli expression in E. coli O157:H7 (52). Transcription
from the csgBAC promoter requires expression of the CsgD-
positive regulator (21). In the present study, we have demon-
strated that csgBAC expression was higher in strains expressing
curli. In one case, this increased level coincided with a higher
level of csgD expression, but in the other strains, levels of csgD
expression were equivalent irrespective of curli expression phe-
notype. Therefore, it appears that curli expression in SF STEC
O157:NM strains can be controlled either by increased csgD
expression or by regulators acting directly on the csgBAC pro-
moter with CsgD. Curli expression is controlled by osmolarity
and various stress responses, in particular those that affect
membrane integrity (27). Regulators controlled by these re-
sponses can act directly on the csgBAC promoter: for example,
RcsB and CpxR, which are modified by phosphorylation. Fur-
ther research will investigate differences in signaling pathways
that control curli expression in SF STEC O157:NM strains.
Although previous studies have shown that in E. coli curli
are generally expressed optimally at temperatures below 30°C
(40), we have demonstrated that SF STEC O157:NM strains
can express curli at 37°C. There is clear evidence that curli are
an important virulence factor. For example, CR-binding vari-
ants of E. coli O157:H7 were more virulent in a mouse model
(53) and expression of curli at 37°C has been reported for a
significant number of human E. coli sepsis isolates (5). Curli
expression may contribute to the virulence of the pathogen in
several ways. First, curli can contribute to increased coloniza-
tion through adherence to host cells (31, 32; this study) and
extracellular matrix (3, 40) and through bacterial aggregation.
Second, the interaction of curliated bacteria with certain host
proteins may facilitate the spread of the bacteria through the
host (3) and as bacteria expressing curli can bind to human
contact-phase proteins, including fibrinogen, the clotting cas-
cade may be inhibited (3). Third, curli can activate the innate
immune system and have been shown to be a pathogen-asso-
ciated molecular pattern recognized by TLR2 (51). This is in
agreement with an earlier study which demonstrated that curli
induce the proinflammatory cytokines tumor necrosis factor
alpha, interleukin-6, and interleukin-8 (5). This final point may
be critical in terms of toxin translocation during SF STEC
O157:NM infections as there is evidence that toxin circulates
on the surface of neutrophils (50). Therefore, the more inflam-
mation that is induced by bacteria in the gastrointestinal tract,
the more neutrophils are recruited that could traffic toxin into
the bloodstream via the lymph system.
In conclusion, the emergence of SF STEC O157:NM strains
is of concern since these pathogens appear to be associated
with a higher incidence of HUS compared to the more com-
mon NSF STEC O157:H7 strains. We investigated potential
factors which could account for increased virulence and found
that, under the in vitro conditions investigated, SF STEC
O157:NM can colonize a human colon cell line at higher levels
than NSF STEC O157:H7. We have shown that curli are the
major factor contributing to this increased adherence observed
in vitro. However, the ability of SF STEC O157:NM cells to
express functional type 1 fimbriae and Sfp fimbriae on their
surface (38, 48; this study) suggests that these adhesins are also
likely to contribute to the adherence of these pathogens in
vivo. The ability of SF STEC O157:NM to express fimbrial
adhesins and colonize the human intestine at higher levels
could have serious implications for human health where the
presence of greater bacterial numbers, and perhaps more per-
sistent colonization, in the intestine leads to higher toxin levels
and associated sequelae.
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